Sato, Yuta
Tanaka, Yoshihiro http://orcid.org/0000-0002-0300-7924
Imai, Takeharu
Hatanaka, Yuji
Okumura, Naoki
Matsuhashi, Nobuhisa
Takahashi, Takao
Yoshida, Kazuhiro
Article History
Received: 14 January 2021
Accepted: 20 April 2021
First Online: 27 April 2021
Declarations
:
: This case report was approved by the ethics committee of Gifu University School of Medicine (approved ID: 2020-172).
: Written informed consent was obtained from the patient for publication of this case report and accompanying images. A copy of the patient’s written consent is available for review by the Editor-in-Chief of this journal.
: Kazuhiro Yoshida has received research funding from Asahi KASEI Co., Ltd., CHUGAI PHARMACEUTICAL CO., LTD., Covidien Japan, DAIICHI SANKYO COMPANY, LIMITED, Eisai Co., Ltd., Eli Lilly Japan K.K., Johnson & Johnson K.K., Merck Serono Co., Ltd., MSD K.K., Nippon Kayaku Co., Ltd., Novartis Pharma K.K., ONO PHARMACEUTICAL CO., LTD., Otsuka Pharmaceutical Co., Ltd., Sanofi K.K., TAIHO PHARMACEUTICAL CO., LTD., Takeda Pharmaceutical Co., Ltd., TSUMURA & CO., Yakult Honsha Co. Ltd., ABBOTT JAPAN CO., LTD., AbbVie GK, Astellas Pharma Inc., Biogen Japan Ltd., CELGENE CORPORATION, GlaxoSmithKline K.K., KCI, Koninklijke Philips N.V., Kyouwa Hakkou Kirin Co., Ltd., Meiji Seika Pharma Co., Ltd., Toray Medical Co., Ltd., KAKEN PHARMACEUTICAL CO., LTD.; honoraria from Asahi KASEI Co., Ltd., CHUGAI PHARMACEUTICAL CO., LTD., Covidien Japan, DAIICHI SANKYO COMPANY, LIMITED, Eisai Co., Ltd., Eli Lilly Japan K.K., Johnson & Johnson K.K., Merck Serono Co., Ltd., MSD K.K., Nippon Kayaku Co., Ltd., Novartis Pharma K.K., ONO PHARMACEUTICAL CO., LTD., Otsuka Pharmaceutical Co., Ltd., Sanofi K.K., TAIHO PHARMACEUTICAL CO., LTD., Takeda Pharmaceutical Co., Ltd., TSUMURA & CO., Yakult Honsha Co., Ltd., AstraZeneca K.K., Bristol-Myers Squibb., Denka Company Limited, EA Pharma Co., Ltd., Olympus Corporation., Pfizer Japan Inc., SANWA KAGAKU KENKYUSHO CO., LTD., SBI Pharmaceuticals Co., Ltd., TEIJIN PHARMA LIMITED., Terumo Corporation; and others from Yakult Honsha Co., Ltd. (no involvement in intellectual property) outside the submitted work. Yoshihiro Tanaka and other co-authors declare that they have no conflicts of interest.